[
  {
    "ts": null,
    "headline": "FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma",
    "summary": "FDA accepts and grants priority review to Bristol Myers' NDA for iberdomide combo in relapsed or refractory multiple myeloma. A decision is due on Aug. 17, 2026.",
    "url": "https://finnhub.io/api/news?id=7447e26576157d5a0440d825da43ccf31756b18e20cde91c870e1cf492de14ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771432260,
      "headline": "FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma",
      "id": 139138738,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "FDA accepts and grants priority review to Bristol Myers' NDA for iberdomide combo in relapsed or refractory multiple myeloma. A decision is due on Aug. 17, 2026.",
      "url": "https://finnhub.io/api/news?id=7447e26576157d5a0440d825da43ccf31756b18e20cde91c870e1cf492de14ec"
    }
  },
  {
    "ts": null,
    "headline": "Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development",
    "summary": "BAAR, Switzerland, February 18, 2026--Evinova announces strategic collaborations with Astellas, AstraZeneca and Bristol Myers Squibb advancing its AI-native platform",
    "url": "https://finnhub.io/api/news?id=742f36bcbc90cdaf7c9c07238b03971ba655d1bebb96f2b7da3de6441ad0ccca",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771427400,
      "headline": "Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform to Accelerate Global Clinical Development",
      "id": 139136707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BAAR, Switzerland, February 18, 2026--Evinova announces strategic collaborations with Astellas, AstraZeneca and Bristol Myers Squibb advancing its AI-native platform",
      "url": "https://finnhub.io/api/news?id=742f36bcbc90cdaf7c9c07238b03971ba655d1bebb96f2b7da3de6441ad0ccca"
    }
  },
  {
    "ts": null,
    "headline": "BioArctic AB (BRCTF) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Partnerships ...",
    "summary": "BioArctic AB (BRCTF) reports a transformative year with significant financial growth, new project expansions, and successful global partnerships, despite challenges in European markets.",
    "url": "https://finnhub.io/api/news?id=8633915fb7b1c02947badfacb994d8b33db642ed89db6f3e381b4bc1f00c6c13",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771426913,
      "headline": "BioArctic AB (BRCTF) Q4 2025 Earnings Call Highlights: Record Growth and Strategic Partnerships ...",
      "id": 139136708,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BioArctic AB (BRCTF) reports a transformative year with significant financial growth, new project expansions, and successful global partnerships, despite challenges in European markets.",
      "url": "https://finnhub.io/api/news?id=8633915fb7b1c02947badfacb994d8b33db642ed89db6f3e381b4bc1f00c6c13"
    }
  },
  {
    "ts": null,
    "headline": "Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo",
    "summary": "CYTK secures EU approval for Myqorzo in symptomatic obstructive HCM, expanding its first commercial drug across major global markets.",
    "url": "https://finnhub.io/api/news?id=ce264957055fba50b5640d0f8f7e32a1886514730166d6949cf8cbfb109d4f35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771425120,
      "headline": "Cytokinetics Wins EU Approval for Cardiovascular Drug Myqorzo",
      "id": 139136959,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "CYTK secures EU approval for Myqorzo in symptomatic obstructive HCM, expanding its first commercial drug across major global markets.",
      "url": "https://finnhub.io/api/news?id=ce264957055fba50b5640d0f8f7e32a1886514730166d6949cf8cbfb109d4f35"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
    "summary": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
    "url": "https://finnhub.io/api/news?id=ed19358bc61bc5411b8ccd08d458eb0523fcbeeed031db84d14f0700816c4ad8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771422295,
      "headline": "Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade)",
      "id": 139138311,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=ed19358bc61bc5411b8ccd08d458eb0523fcbeeed031db84d14f0700816c4ad8"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors",
    "summary": "Bristol-Myers Squibb (BMY) offers a high 4.21% dividend yield with a strong history of increases, backed by solid earnings. Investors should note its high payout ratio and debt.",
    "url": "https://finnhub.io/api/news?id=d1a0913d4107700e5a62f72c41a89df54cd2aaf12789513723c82cb9d016edc1",
    "source": "ChartMill",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771414855,
      "headline": "Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors",
      "id": 139132459,
      "image": "https://www.chartmill.com/images/uploads/Best_Dividend_500_264px_webp_9524a3945f.webp",
      "related": "BMY",
      "source": "ChartMill",
      "summary": "Bristol-Myers Squibb (BMY) offers a high 4.21% dividend yield with a strong history of increases, backed by solid earnings. Investors should note its high payout ratio and debt.",
      "url": "https://finnhub.io/api/news?id=d1a0913d4107700e5a62f72c41a89df54cd2aaf12789513723c82cb9d016edc1"
    }
  },
  {
    "ts": null,
    "headline": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
    "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease.",
    "url": "https://finnhub.io/api/news?id=60565f5c6cdf402f39dcf05d2aa2a572b3cde3073cbb9dd3c570f07f65a2e0b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771410917,
      "headline": "FDA accepts BMS protein degrader for review; Disc rare disease drug rejected",
      "id": 139136709,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease.",
      "url": "https://finnhub.io/api/news?id=60565f5c6cdf402f39dcf05d2aa2a572b3cde3073cbb9dd3c570f07f65a2e0b7"
    }
  },
  {
    "ts": null,
    "headline": "This State Has More Millionaires Per Capita Than Any Other",
    "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
    "url": "https://finnhub.io/api/news?id=0b69ba08e8438c795b2a5c5ba414e722c5a52abf4d7d7d1c6eaa471cfa88f4ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771381280,
      "headline": "This State Has More Millionaires Per Capita Than Any Other",
      "id": 139129002,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "There are many ways to describe America. Some might call it a veritable patchwork of diverse cultures and social strata. That’s a fancy way of saying that prosperity is concentrated in some U.S. states more than in others. As a result, a handful of America’s 50 states have more millionaires than others. By the process ... This State Has More Millionaires Per Capita Than Any Other",
      "url": "https://finnhub.io/api/news?id=0b69ba08e8438c795b2a5c5ba414e722c5a52abf4d7d7d1c6eaa471cfa88f4ed"
    }
  }
]